Transgene Biotek incorporates wholly owned subsidiary company

24 Dec 2020 Evaluate

Transgene Biotek has incorporated a wholly owned subsidiary company namely 'Peroral Bio' on December 23, 2020. The company has incorporated a wholly owned subsidiary company for carrying out the business of Pharmaceutical and biotechnology related operations and formulations.

Transgene Biotek (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs.

Transgene Biotek Share Price

7.07 0.14 (2.02%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.